Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
May enhance liver function and support hepatic detoxification pathways [9] [11]
PubChem Compound Summary
Medications that can enhance the activity of insulin (so-called incretin mimetics) can help to overcome insulin resistance caused by SGAs (and potentially by other psychotropic medications) and essentially lead to weight loss through enhanced fuel efficiency. Metformin, typically dosed up to 1,000 mg twice daily with meals, has increasingly become recognized as a first-line strategy to attenuate weight gain and glycemic dysregulation from SGAs via its ability to reduce insulin resistance
Circulating insulin-like growth factor I in relation to melanoma risk in the European Prospective Investigation into Cancer and Nutrition
US$ 26.07
US$ 29.88
US$ 23.44
US$ 24.22
US$ 20.39
US$ 28.26
US$ 25.45
US$ 24.79
US$ 20.92
